Cite
HARVARD Citation
Kim, B. et al. (2018). 31. Neoadjuvant Endocrine Therapy in Breast Cancer Up-Regulates the Cytotoxic Drug Pump ABCG2/BCRP, and May Lead to Resistance to Subsequent Chemotherapy. European journal of surgical oncology. 44 (11), pp. 1840-. [Online].